Page 1 of 1

New Data for MS drug Tysabri released at AAN annual meeting

Posted: Thu May 01, 2014 5:35 am
by MSUK
- New Tysabri® analysis shows improved walking speed in significant number of MS patients.

- Additional data show escalation to Tysabri following relapse improves clinical outcomes compared to remaining on or switching between first-line Interferon Beta and Glatiramer Acetate.............. Read More - http://www.ms-uk.org/tysabri

Re: New Data for MS drug Tysabri released at AAN annual meet

Posted: Thu May 01, 2014 6:59 pm
by HarryZ
MSUK wrote:- New Tysabri® analysis shows improved walking speed in significant number of MS patients.

- Additional data show escalation to Tysabri following relapse improves clinical outcomes compared to remaining on or switching between first-line Interferon Beta and Glatiramer Acetate.............. Read More - http://www.ms-uk.org/tysabri
Data presented by Biogen!! Remember this was the company that told us Tysabri was safe when it was first released and then held off announcing to the world the news about PML while its execs made millions by selling their stock. Have to admit though that it's a good marketing ploy to boost sales.